• FDA Scientific Conference Grant Program Project Spotlight 
• What is the FDA Scientific Conference Grant Program?
• What funding is available?
• Who are the current grantees?
• Who may I contact for more information?
• FDA Scientific Conference Grant Program Fact Sheet (Version April 2023)

FDA Scientific Conference Grant Program Project Spotlight

What is the FDA Scientific Conference Grant Program?

FDA recognizes the value of supporting high quality, small conferences and scientific meetings relevant to its public health mission. This funding opportunity supports small conferences or scientific meetings. Examples include a symposium, seminar, workshop or any formal meeting, whether conducted face-to-face or virtually. The purpose is to exchange information and explore a defined subject, issue, or area of concern impacting public health within the scope of the FDA's mission.

"PAR-23-072: FDA Support for Conferences and Scientific Meetings” is a unique funding opportunity that combines the application and award process for all participating Centers within the FDA. This consolidated announcement streamlines the application process for applicants. Prospective applicants will need to request advanced permission to apply to the FDA Center that is aligned with the foci areas of their conference or scientific meeting.

What funding is available?

Information regarding funding can be found in the funding opportunity announcement.

The application due dates for the current FOA (due by 11:59 Eastern Time) are:

• FY23: April 12, 2023
• FY24: October 12, 2023 & April 14, 2024
• FY25: October 11, 2024 & April 11, 2025
• FY26: October 10, 2025

A letter requesting advance permission to submit a conference application is required and must be received via e-mail no later than eight (8) weeks prior to the application due date. Applications without advanced permission to apply by the cognizant funding office will not be accepted or reviewed. The requirements for the Letters of Intent can be found in the funding opportunity announcement.

Who are the current grantees?

• Total of 12 awardees: AAFCO; AFDO; CASA; DC DOH; ISS; NASDA; NCIMS; NEHA; NERO; SARL; WAFDO; AFDOSS.
• $583K in funding under this grant program.

Who may I contact for more information?

Specific questions on this program for current grantees can be directed to the appropriate Office of Partnerships' contact within the Division of Partnership Investments and Agreements. Please visit the Office of Partnerships Contacts webpage to obtain a downloaded version of the staffing roster. 

General questions may be directed to the Office of Partnerships' general mailbox: op.feedback@fda.hhs.gov.

Prospective applicants and current applicants must contact the Office of Acquisitions & Grants Services (OAGS) point of contact listed within the Notice of Funding Opportunity (NOFO) under Section VII Agency Contacts at the bottom of the announcement.